Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes

Martín G. Vila Petroff, Josephine M. Egan, Xiaolin Wang, Steven J. Sollott

Research output: Contribution to journalArticle

Abstract

The gut hormone, glucagon-like peptide-1 (GLP-1), which is secreted in nanomolar amounts in response to nutrients in the intestinal lumen, exerts cAMP/protein kinase A-mediated insulinotropic actions in target endocrine tissues, but its actions in heart cells are unknown. GLP-1 (10 nmol/L) increased intracellular cAMP (from 5.7±0.5 to 13.1±0.12 pmol/mg protein) in rat cardiac myocytes. The effects of cAMP-doubling concentrations of both GLP-1 and isoproterenol (ISO, 10 nmol/L) on contraction amplitude, intracellular Ca2+ transient (CaT), and pHi in indo-1 and seminaphthorhodafluor (SNARF)-1 loaded myocytes were compared. Whereas ISO caused a characteristic increase (above baseline) in contraction amplitude (160±34%) and CaT (70±5%), GLP-1 induced a significant decrease in contraction amplitude (-27±5%) with no change in the CaT after 20 minutes. Neither pertussis toxin treatment nor exposure to the cGMP-stimulated phosphodiesterase (PDE2) inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine or the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine nor the phosphatase inhibitors okadaic acid or calyculin A unmasked an ISO-mimicking response of GLP-1. In SNARF-1-loaded myocytes, however, both ISO and GLP-1 caused an intracellular acidosis (ΔpHi -0.09±0.02 and -0.08±0.03, respectively). The specific GLP-1 antagonist exendin 9-39 and the cAMP inhibitory analog Rp-8CPT-cAMPS inhibited both the GLP-1-induced intracellular acidosis and the negative contractile effect. We conclude that in contrast to β-adrenergic signaling, GLP-1 increases cAMP but fails to augment contraction, suggesting the existence of functionally distinct adenylyl cyclase/cAMP/protein kinase A compartments, possibly determined by unique receptor signaling microdomains that are not controlled by pertussis toxin-sensitive G proteins or by enhanced local PDE or phosphatase activation. Furthermore, GLP-1 elicits a cAMP-dependent modest negative inotropic effect produced by a decrease in myofilament-Ca2+ responsiveness probably resulting from intracellular acidification.

Original languageEnglish (US)
Pages (from-to)445-452
Number of pages8
JournalCirculation Research
Volume89
Issue number5
StatePublished - Aug 31 2001
Externally publishedYes

Fingerprint

Glucagon-Like Peptide 1
Cardiac Myocytes
Pertussis Toxin
Cyclic AMP-Dependent Protein Kinases
Acidosis
Phosphoric Monoester Hydrolases
Muscle Cells
Glucagon-Like Peptides
1-Methyl-3-isobutylxanthine
Okadaic Acid
Phosphodiesterase Inhibitors
Myofibrils
Isoproterenol
GTP-Binding Proteins
Adenylyl Cyclases
Adrenergic Agents
Hormones
Food

Keywords

  • Calcium
  • cAMP
  • Cardiac myocytes
  • Glucagon-like peptide-1

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Vila Petroff, M. G., Egan, J. M., Wang, X., & Sollott, S. J. (2001). Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circulation Research, 89(5), 445-452.

Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. / Vila Petroff, Martín G.; Egan, Josephine M.; Wang, Xiaolin; Sollott, Steven J.

In: Circulation Research, Vol. 89, No. 5, 31.08.2001, p. 445-452.

Research output: Contribution to journalArticle

Vila Petroff, MG, Egan, JM, Wang, X & Sollott, SJ 2001, 'Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes', Circulation Research, vol. 89, no. 5, pp. 445-452.
Vila Petroff, Martín G. ; Egan, Josephine M. ; Wang, Xiaolin ; Sollott, Steven J. / Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. In: Circulation Research. 2001 ; Vol. 89, No. 5. pp. 445-452.
@article{8728822734564132ae195d8e4ac74aaf,
title = "Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes",
abstract = "The gut hormone, glucagon-like peptide-1 (GLP-1), which is secreted in nanomolar amounts in response to nutrients in the intestinal lumen, exerts cAMP/protein kinase A-mediated insulinotropic actions in target endocrine tissues, but its actions in heart cells are unknown. GLP-1 (10 nmol/L) increased intracellular cAMP (from 5.7±0.5 to 13.1±0.12 pmol/mg protein) in rat cardiac myocytes. The effects of cAMP-doubling concentrations of both GLP-1 and isoproterenol (ISO, 10 nmol/L) on contraction amplitude, intracellular Ca2+ transient (CaT), and pHi in indo-1 and seminaphthorhodafluor (SNARF)-1 loaded myocytes were compared. Whereas ISO caused a characteristic increase (above baseline) in contraction amplitude (160±34{\%}) and CaT (70±5{\%}), GLP-1 induced a significant decrease in contraction amplitude (-27±5{\%}) with no change in the CaT after 20 minutes. Neither pertussis toxin treatment nor exposure to the cGMP-stimulated phosphodiesterase (PDE2) inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine or the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine nor the phosphatase inhibitors okadaic acid or calyculin A unmasked an ISO-mimicking response of GLP-1. In SNARF-1-loaded myocytes, however, both ISO and GLP-1 caused an intracellular acidosis (ΔpHi -0.09±0.02 and -0.08±0.03, respectively). The specific GLP-1 antagonist exendin 9-39 and the cAMP inhibitory analog Rp-8CPT-cAMPS inhibited both the GLP-1-induced intracellular acidosis and the negative contractile effect. We conclude that in contrast to β-adrenergic signaling, GLP-1 increases cAMP but fails to augment contraction, suggesting the existence of functionally distinct adenylyl cyclase/cAMP/protein kinase A compartments, possibly determined by unique receptor signaling microdomains that are not controlled by pertussis toxin-sensitive G proteins or by enhanced local PDE or phosphatase activation. Furthermore, GLP-1 elicits a cAMP-dependent modest negative inotropic effect produced by a decrease in myofilament-Ca2+ responsiveness probably resulting from intracellular acidification.",
keywords = "Calcium, cAMP, Cardiac myocytes, Glucagon-like peptide-1",
author = "{Vila Petroff}, {Mart{\'i}n G.} and Egan, {Josephine M.} and Xiaolin Wang and Sollott, {Steven J.}",
year = "2001",
month = "8",
day = "31",
language = "English (US)",
volume = "89",
pages = "445--452",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes

AU - Vila Petroff, Martín G.

AU - Egan, Josephine M.

AU - Wang, Xiaolin

AU - Sollott, Steven J.

PY - 2001/8/31

Y1 - 2001/8/31

N2 - The gut hormone, glucagon-like peptide-1 (GLP-1), which is secreted in nanomolar amounts in response to nutrients in the intestinal lumen, exerts cAMP/protein kinase A-mediated insulinotropic actions in target endocrine tissues, but its actions in heart cells are unknown. GLP-1 (10 nmol/L) increased intracellular cAMP (from 5.7±0.5 to 13.1±0.12 pmol/mg protein) in rat cardiac myocytes. The effects of cAMP-doubling concentrations of both GLP-1 and isoproterenol (ISO, 10 nmol/L) on contraction amplitude, intracellular Ca2+ transient (CaT), and pHi in indo-1 and seminaphthorhodafluor (SNARF)-1 loaded myocytes were compared. Whereas ISO caused a characteristic increase (above baseline) in contraction amplitude (160±34%) and CaT (70±5%), GLP-1 induced a significant decrease in contraction amplitude (-27±5%) with no change in the CaT after 20 minutes. Neither pertussis toxin treatment nor exposure to the cGMP-stimulated phosphodiesterase (PDE2) inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine or the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine nor the phosphatase inhibitors okadaic acid or calyculin A unmasked an ISO-mimicking response of GLP-1. In SNARF-1-loaded myocytes, however, both ISO and GLP-1 caused an intracellular acidosis (ΔpHi -0.09±0.02 and -0.08±0.03, respectively). The specific GLP-1 antagonist exendin 9-39 and the cAMP inhibitory analog Rp-8CPT-cAMPS inhibited both the GLP-1-induced intracellular acidosis and the negative contractile effect. We conclude that in contrast to β-adrenergic signaling, GLP-1 increases cAMP but fails to augment contraction, suggesting the existence of functionally distinct adenylyl cyclase/cAMP/protein kinase A compartments, possibly determined by unique receptor signaling microdomains that are not controlled by pertussis toxin-sensitive G proteins or by enhanced local PDE or phosphatase activation. Furthermore, GLP-1 elicits a cAMP-dependent modest negative inotropic effect produced by a decrease in myofilament-Ca2+ responsiveness probably resulting from intracellular acidification.

AB - The gut hormone, glucagon-like peptide-1 (GLP-1), which is secreted in nanomolar amounts in response to nutrients in the intestinal lumen, exerts cAMP/protein kinase A-mediated insulinotropic actions in target endocrine tissues, but its actions in heart cells are unknown. GLP-1 (10 nmol/L) increased intracellular cAMP (from 5.7±0.5 to 13.1±0.12 pmol/mg protein) in rat cardiac myocytes. The effects of cAMP-doubling concentrations of both GLP-1 and isoproterenol (ISO, 10 nmol/L) on contraction amplitude, intracellular Ca2+ transient (CaT), and pHi in indo-1 and seminaphthorhodafluor (SNARF)-1 loaded myocytes were compared. Whereas ISO caused a characteristic increase (above baseline) in contraction amplitude (160±34%) and CaT (70±5%), GLP-1 induced a significant decrease in contraction amplitude (-27±5%) with no change in the CaT after 20 minutes. Neither pertussis toxin treatment nor exposure to the cGMP-stimulated phosphodiesterase (PDE2) inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine or the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine nor the phosphatase inhibitors okadaic acid or calyculin A unmasked an ISO-mimicking response of GLP-1. In SNARF-1-loaded myocytes, however, both ISO and GLP-1 caused an intracellular acidosis (ΔpHi -0.09±0.02 and -0.08±0.03, respectively). The specific GLP-1 antagonist exendin 9-39 and the cAMP inhibitory analog Rp-8CPT-cAMPS inhibited both the GLP-1-induced intracellular acidosis and the negative contractile effect. We conclude that in contrast to β-adrenergic signaling, GLP-1 increases cAMP but fails to augment contraction, suggesting the existence of functionally distinct adenylyl cyclase/cAMP/protein kinase A compartments, possibly determined by unique receptor signaling microdomains that are not controlled by pertussis toxin-sensitive G proteins or by enhanced local PDE or phosphatase activation. Furthermore, GLP-1 elicits a cAMP-dependent modest negative inotropic effect produced by a decrease in myofilament-Ca2+ responsiveness probably resulting from intracellular acidification.

KW - Calcium

KW - cAMP

KW - Cardiac myocytes

KW - Glucagon-like peptide-1

UR - http://www.scopus.com/inward/record.url?scp=0035980166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035980166&partnerID=8YFLogxK

M3 - Article

C2 - 11532906

AN - SCOPUS:0035980166

VL - 89

SP - 445

EP - 452

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -